ANEST IWATA Management

Management criteria checks 2/4

ANEST IWATA's CEO is Shinichi Fukase, appointed in Jan 2022, has a tenure of 2.33 years. directly owns 0.081% of the company’s shares, worth ¥43.90M. The average tenure of the management team and the board of directors is 2.3 years and 3.9 years respectively.

Key information

Shinichi Fukase

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	2.3yrs
CEO ownership	0.08%
Management average tenure	2.3yrs
Board average tenure	3.9yrs

Recent management updates

Recent updates

ANEST IWATA's (TSE:6381) Dividend Will Be Increased To ¥23.00

Mar 11

ANEST IWATA (TSE:6381) Is Paying Out A Larger Dividend Than Last Year

Feb 26

CEO

Shinichi Fukase (58 yo)

2.3yrs

Tenure

Mr. Shinichi Fukase serves as President and Chief Executive Officer at ANEST IWATA Corporation since April 2022. He served as Corporate Officer at ANEST IWATA Corporation and serves as its Chief Operating...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Takahiro Tsubota	Executive Chairman	22.9yrs	no data	no data
Shinichi Fukase	President	2.3yrs	no data	0.081% ¥ 43.9m
Eisuke Miyoshi	Managing Executive Officer	5.3yrs	no data	0.012% ¥ 6.5m
Hajime Iwata	COO of Air Energy Division & Development Technology Manager	2.3yrs	no data	no data
Katsumi Takeda	Managing Executive Officer	no data	no data	0.049% ¥ 26.8m
Kenichi Osawa	Senior Managing Executive Officer	no data	no data	0.011% ¥ 6.0m

2.3yrs

Average Tenure

57yo

Average Age

Experienced Management: 6381's management team is considered experienced (2.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Takahiro Tsubota	Executive Chairman	22.9yrs	no data	no data
Shinichi Fukase	President	5.3yrs	no data	0.081% ¥ 43.9m
Eisuke Miyoshi	Managing Executive Officer	less than a year	no data	0.012% ¥ 6.5m
Katsumi Takeda	Managing Executive Officer	1.8yrs	no data	0.049% ¥ 26.8m
Kenichi Osawa	Senior Managing Executive Officer	4.3yrs	no data	0.011% ¥ 6.0m
Yoshitsugu Asai	Independent Director	3.9yrs	no data	0.027% ¥ 14.8m
Reiko Ohashi	Independent Director	2.9yrs	no data	0.0066% ¥ 3.6m
Kazumichi Matsuki	Independent Director	5.9yrs	no data	0.014% ¥ 7.8m
Makoto Shimamoto	Independent Director	less than a year	no data	no data
Yuko Shirai	Independent Director	2.9yrs	no data	0.0080% ¥ 4.3m
Kyosuke Oshima	Independent Director	8.9yrs	no data	0.033% ¥ 17.9m

3.9yrs

Average Tenure

63yo

Average Age

Experienced Board: 6381's board of directors are considered experienced (3.9 years average tenure).

ANEST IWATA Management

Management criteria checks 2/4

Key information

Recent management updates

High number of new directors

ANEST IWATA Corporation, Annual General Meeting, Jun 23, 2023

ANEST IWATA Corporation, Annual General Meeting, Jun 24, 2022

Recent updates

Upcoming dividend of JP¥23.00 per share

ANEST IWATA's (TSE:6381) Dividend Will Be Increased To ¥23.00

ANEST IWATA Corporation to Report Fiscal Year 2024 Results on May 09, 2024

Now 21% undervalued

ANEST IWATA (TSE:6381) Is Paying Out A Larger Dividend Than Last Year

Third quarter 2024 earnings released: EPS: JP¥25.00 (vs JP¥27.09 in 3Q 2023)

ANEST IWATA Corporation (TSE:6381) announces an Equity Buyback for 1,500,000 shares, representing 3.69% for ¥1,500 million.

ANEST IWATA Corporation to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: JP¥30.80 (vs JP¥28.79 in 2Q 2023)

New major risk - Revenue and earnings growth

High number of new directors

Upcoming dividend of JP¥17.00 per share at 3.3% yield

ANEST IWATA Corporation to Report Q2, 2024 Results on Nov 09, 2023

First quarter 2024 earnings released: EPS: JP¥34.00 (vs JP¥19.94 in 1Q 2023)

ANEST IWATA Corporation to Report Q1, 2024 Results on Aug 09, 2023

ANEST IWATA Corporation Proposes Dividend for Year-End for the Fiscal Year 2022

Full year 2023 earnings released: EPS: JP¥108 (vs JP¥86.31 in FY 2022)

ANEST IWATA Corporation, Annual General Meeting, Jun 23, 2023

Upcoming dividend of JP¥20.00 per share at 3.3% yield

Third quarter 2023 earnings released: EPS: JP¥27.07 (vs JP¥20.57 in 3Q 2022)

ANEST IWATA Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

ANEST IWATA Corporation to Report Q3, 2023 Results on Feb 09, 2023

Second quarter 2023 earnings released: EPS: JP¥28.79 (vs JP¥24.05 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥28.79 (vs JP¥24.05 in 2Q 2022)

ANEST IWATA Corporation Provides Dividend Guidance for the Year Ending March 31, 2023

Upcoming dividend of JP¥15.00 per share

ANEST IWATA Corporation to Report Q2, 2023 Results on Nov 09, 2022

ANEST IWATA Corporation Provides Dividend Guidance for the Second Quarter and for the Full Year 2022

First quarter 2023 earnings released: EPS: JP¥19.94 (vs JP¥17.04 in 1Q 2022)

Now 21% undervalued

ANEST IWATA Corporation to Report Q1, 2023 Results on Aug 09, 2022

Anest Iwata Corporation Announces Dividend for the Fiscal Year 2021, payable on June 27, 2022 and Provides Dividend Guidance for the Second Quarter 2022

ANEST IWATA Corporation, Annual General Meeting, Jun 24, 2022

Full year 2022 earnings released: EPS: JP¥86.31 (vs JP¥63.33 in FY 2021)

ANEST IWATA Corporation to Report Fiscal Year 2022 Results on May 10, 2022

Upcoming dividend of JP¥13.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

ANEST IWATA Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

ANEST IWATA Corporation has filed an IPO.

Second quarter 2022 earnings released: EPS JP¥24.05 (vs JP¥16.75 in 2Q 2021)

Upcoming dividend of JP¥12.00 per share

Full year 2021 earnings released: EPS JP¥63.33 (vs JP¥65.12 in FY 2020)

Upcoming dividend of JP¥12.00 per share

Third quarter 2021 earnings released: EPS JP¥19.55 (vs JP¥12.51 in 3Q 2020)

New 90-day high: JP¥1,149

ANEST IWATA Corporation to Report Q3, 2021 Results on Feb 10, 2021

New 90-day high: JP¥997

ANEST IWATA Corporation to Report Q2, 2021 Results on Nov 10, 2020

ANEST IWATA Corporation to Report Q1, 2021 Results on Aug 06, 2020

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age